CN104745500B - One plant production L phenylalanines bacterial strain and its application - Google Patents

One plant production L phenylalanines bacterial strain and its application Download PDF

Info

Publication number
CN104745500B
CN104745500B CN201310752842.8A CN201310752842A CN104745500B CN 104745500 B CN104745500 B CN 104745500B CN 201310752842 A CN201310752842 A CN 201310752842A CN 104745500 B CN104745500 B CN 104745500B
Authority
CN
China
Prior art keywords
phenylalanine
escherichia coli
fermentation
glucose
cctcc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310752842.8A
Other languages
Chinese (zh)
Other versions
CN104745500A (en
Inventor
吴伟斌
施巧琴
翁雪清
黄钦耿
赵燕玉
陈炳生
吴松刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaxian County New Creation Biological Technology Co ltd
Original Assignee
Shaxian County New Creation Biological Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaxian County New Creation Biological Technology Co ltd filed Critical Shaxian County New Creation Biological Technology Co ltd
Priority to CN201310752842.8A priority Critical patent/CN104745500B/en
Publication of CN104745500A publication Critical patent/CN104745500A/en
Application granted granted Critical
Publication of CN104745500B publication Critical patent/CN104745500B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1085Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/22Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
    • C12P13/222Phenylalanine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y205/00Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/010543-Deoxy-7-phosphoheptulonate synthase (2.5.1.54)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/01Hydro-lyases (4.2.1)
    • C12Y402/01051Prephenate dehydratase (4.2.1.51)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y504/00Intramolecular transferases (5.4)
    • C12Y504/99Intramolecular transferases (5.4) transferring other groups (5.4.99)
    • C12Y504/99005Chorismate mutase (5.4.99.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses one plant of bacterial strain for producing L phenylalanines and its application.One plant of recombination bacillus coli MD1078 disclosed by the invention(Escherichia coli MD1078), its deposit number is CCTCC NO:M2013509.The bacterial strain is in 100L automatic fermenters, and 36 DEG C, dissolved oxygen 35% 50%, fermentation time are that L phenylalanine yield reaches 86.5g/L under conditions of 48 hours.The ability of Escherichia coli MD1078 production L phenylalanines is high, is had broad application prospects in the actual production of L phenylalanines.

Description

One plant production L-phenylalanine bacterial strain and its application
Technical field
The present invention relates to one plant of bacterial strain for producing L-phenylalanine and its application.
Background technology
L-phenylalanine(L-phenylalanine)It is that human body and animal can not in vivo voluntarily for white crystalline powder One of necessary amino acid of synthesis, is widely used in the fields such as food, feed, medicine and cosmetics.L-phenylalanine is used as conjunction Into Aspartame(Aspartame)One of two kinds of raw materials, in the dipeptide sweetener Aspartame for preparing low in calories, high sugariness Application it is increasingly extensive, the market demand of L-phenylalanine increases sharply.Other L-phenylalanine be also antineoplastic and The required raw material of amino acid transfusion preparation, with its continually developing in field of medicaments, demand is also continuously increased.Therefore, it is right The research of L-phenylalanine biosynthesis pathway, the improvement of L-phenylalanine producing strains and more next to the research of its industrialized production More it is valued by people.
The production method of domestic and international L-phenylalanine mainly has hydrolysis extraction process, chemical synthesis, enzyme process and fermentation method etc.. Because L-phenylalanine content is relatively low in native protein, hydrolysis extraction process is rarely employed;The complex process of chemical synthesis, cost It is higher, substantially replaced abroad by enzyme process and fermentation method.But because the price of substrate and enzyme is higher and limited source, enzyme process should With also restrained;Because microorganism direct fermentation can utilize raw material cheap and easy to get, it can at normal temperatures and pressures carry out again, be The main stream approach of L-phenylalanine is produced both at home and abroad at present, with larger competitive advantage.But it is due to that L-phenylalanine etc. is whole Product has strong feedback inhibition to the key enzyme on the aromatic amino acid metabolic pathway of synthesizing in wild strain body, Prevent its cell from largely accumulating phenylalanine, therefore to carry out real attenuation production, just need acquisition production L-phenylalanine badly The high bacterial strain of ability.
When so-called fallibility round pcr refers to amplifying target genes in vitro, using the low fidelity of Taq enzyme, adjust simultaneously Whole reaction condition, such as improves magnesium ion concentration, the proportional concentration method for adding manganese ion, changing dNTP, with certain frequency Base mispairing is randomly incorporated into target gene, causes the random mutation of target gene to constitute mutation library, then selects or screen Go out the mutant of needs.
The content of the invention
It is an object of the invention to provide one plant of bacterial strain for producing L-phenylalanine and its application.
One plant of recombination bacillus coli MD1078 that the present invention is provided(Escherichia coli MD1078), its preservation volume Number be CCTCC NO:M 2013509.
Deposit number is CCTCC NO:Application of M 2013509 Escherichia coli in production L-phenylalanine is fallen within Protection scope of the present invention.
A kind of method for producing L-phenylalanine falls within protection scope of the present invention, and this method comprises the following steps:Will Deposit number is CCTCC NO:M2013509 Escherichia coli fermentation culture, obtains L-phenylalanine.
In the above method, composition of the fermentation medium used in the fermented and cultured per 100ml is as follows:
Glucose 2g, ammonium sulfate 2g, sodium citrate 0.05g, magnesium sulfate 0.08g, potassium dihydrogen phosphate 0.1g, dipotassium hydrogen phosphate 0.1g, dusty yeast 0.1g, sodium glutamate 0.05g, MnCl20.2mg, niacin 1mg, CoCl20.01mg, ZnSO40.1mg, CaCl20.5mg, VB11mg, MnCl20.2mg, tyrosine 3mg, surplus is water.
In any of the above-described described method, the condition of the fermentation is 36 DEG C, dissolved oxygen 35%-50%, when in fermentation system Glucose content starts to add glucose when being less than 15g/L, the content of glucose is maintained between 10g/L-15g/L.
In any of the above-described described method, the time of the fermentation is 48 hours.
In any of the above-described described method, the bacterial strain is to access fermentation medium by seed liquor.
In any of the above-described described method, the composition for preparing the every 100ml of culture medium of the seed liquor is as follows:Glucose 3g, ammonium sulfate 1g, magnesium sulfate 0.08g, potassium dihydrogen phosphate 0.1g, dipotassium hydrogen phosphate 0.1g, dusty yeast 0.2g, sodium glutamate 0.08g, MnCl20.25mg, CoCl20.005mg, ZnSO40.15mg, CaCl20.5mg, VB11mg, MnCl20.2mg, tyrosine 3mg, surplus is water.
In any of the above-described described method, condition of culture when prepared by the seed liquor is 36 DEG C, dissolved oxygen is 40%-60%, The content of glucose is 30g/L.
In any of the above-described described method, the incubation time of the seed liquor is 12 hours.
It is demonstrated experimentally that the deposit number provided using the present invention is CCTCC NO:M 2013509 Escherichia coli production L- Phenylalanine, the yield of L-phenylalanine is up to 86.5g/L, it was demonstrated that the ability of bacterial strain production L-phenylalanine of the present invention is very high, Had broad application prospects in the actual production of L-phenylalanine.
Brief description of the drawings
Fig. 1 is pBV220-aroG-pheA plasmids.
Fig. 2 is the HPLC spectrograms of amino acid standard liquid.
Fig. 3 is the HPLC spectrograms of the dilution of Escherichia coli MD1078 fermented liquid supernatants.
The HPLC spectrograms of the dilution of the fermented liquid supernatant of Fig. 4 Escherichia coli 10245.
Embodiment
Experimental method used in following embodiments is conventional method unless otherwise specified.
Material, reagent used etc., unless otherwise specified, are commercially obtained in following embodiments.
PMD-18T is purchased from precious bioengineering(Dalian)Co., Ltd, catalog number is D101A.
PBV220 is purchased from Beijing Ding Guo bio tech ltd.
Escherichia coli(Escherichia coli)Purchased from Chinese industrial Microbiological Culture Collection administrative center (www.china-cicc.org), deposit number is 10245, abbreviation Escherichia coli 10245.
Fermentation medium:50g/L glucose, 10g/L yeast extracts, 3g/L Na2HPO4、1g/L KH2PO4、12g/L NH4Cl、1g/L MgSO4、0.3g/L CaCl2, 6g/L sodium citrates, 0.6g/L sodium glutamates, 2g/L peptones, 20mg/LVB1, Surplus is water.
L-phenylalanine is full of pool purchased from Beijing and taken in the fresh Chemical Engineering Technology research institute, and production number is GF2212.
Prepared as follows per 100ml fermentation tank seed culture mediums:
Glucose 3g, ammonium sulfate 1g, magnesium sulfate 0.08g, potassium dihydrogen phosphate 0.1g, dipotassium hydrogen phosphate 0.1g, dusty yeast 0.2g, sodium glutamate 0.08g, MnCl20.25mg, CoCl20.005mg, ZnSO40.15mg, CaCl20.5mg, VB11mg, MnCl20.2mg, tyrosine 3mg, add water and are settled to 100ml, sterilizing.
Prepared as follows per 100ml ferment tank culture mediums:
Glucose 2g, ammonium sulfate 2g, sodium citrate 0.05g, magnesium sulfate 0.08g, potassium dihydrogen phosphate 0.1g, dipotassium hydrogen phosphate 0.1g, dusty yeast 0.1g, sodium glutamate 0.05g, MnCl20.2mg, niacin 1mg, CoCl20.01mg, ZnSO40.1mg, CaCl20.5mg, VB11mg, MnCl20.2mg, tyrosine 3mg, add water and are settled to 100ml, sterilizing.
Amino acid standard liquid is purchased from Tianjin Bonaaijieer Technology Co., Ltd.
The preparation of embodiment 1, the bacterial strain of production L-phenylalanine
First, recombinant plasmid pBV220-aroG-pheA structure
The genomic DNA of Escherichia coli 10245 is extracted, using it as template, is primer with primer aroG-f and aroG-r, enters Performing PCR is expanded, and obtains aroG genes.
The genomic DNA of Escherichia coli 10245 is extracted, using it as template, is primer with primer pheA-f and pheA-r, enters Performing PCR is expanded, and obtains pheA genes.
EcoR I and the double digestion aroG genes of Kpn I, obtain genetic fragment;The EcoR I and double digestion pMD-18T of Kpn I, is obtained Carrier large fragment;Genetic fragment is connected with carrier large fragment, recombinant plasmid is obtained, pMD-18T-aroG is named as.
Kpn I and the double digestion pheA genes of BamH I, obtain genetic fragment;The Kpn I and double digestion pMD-18T of BamH I, is obtained Carrier large fragment;Genetic fragment is connected with carrier large fragment, recombinant plasmid is obtained, pMD-18T-pheA is named as.
aroG-f:5’-CGGAATTCATGAATTATCAGAACGACGAT-3’
aroG-r:5’-GGGGTACCACCCGCGACGCGCTTTTACTG-3’
pheA-f:5’-GGGGTACCATGACATCGGAAAACCCGTTAC-3’
pheA-r:5’-CGGGATCCTCAGGTTGGATCAACAGGCAC-3’
(Sequence shown in underscore is digestion recognition site)
With Kpn I and the double digestion pMD-18T-aroG of BamH I, carrier large fragment is reclaimed;With Kpn I and the double digestions of BamH I PMD-18T-pheA, reclaims pheA genetic fragments;Carrier large fragment and pheA genetic fragments are connected, recombinant plasmid is obtained, ordered Entitled pMD-aroG-pheA.PMD-aroG-pheA is subjected to sequence verification, as a result correctly.
Plasmid pMD-aroG-pheA is subjected to double digestion with EcoR I and BamH I, aroG-pheA genetic fragments are reclaimed;Will Plasmid pBV220 carries out double digestion with EcoR I and BamH I, reclaims carrier large fragment;By carrier large fragment and aroG-pheA genes Fragment is connected, and is obtained recombinant plasmid, is named as pBV220-aroG-pheA, as shown in figure 1, sequence verification is correct.
2nd, recombinant plasmid pBV220-aroG-pheA promutation
(One)Fallibility PCR is mutated
With plasmid pBV220-aroG-pheA templates, by improving magnesium ion concentration and changing dNTP concentration, fallibility is carried out PCR, makes gene aroG-pheA undergo mutation, and PCR primer is gene aroG-pheA mutation library.
Sense primer aroG-f:5’-CGGAATTCATGAATTATCAGAACGACGAT-3’
Anti-sense primer pheA-r:5’-CGGGATCCTCAGGTTGGATCAACAGGCAC-3’;
(Sequence shown in underscore is digestion recognition site)
Error-prone PCR systems(100μl):
DATP, dCTP, dTTP, dGTP concentration are 100mM/mL, MgCl2Concentration be 25mM/mL, upstream and downstream primer Concentration is 10 μm of ol/L, and the concentration of DNA template is 70ng/ μ L.
PCR programs are:94 DEG C of pre-degeneration 4min;94 DEG C of denaturation 1min, 56 DEG C of annealing 1min, 72 DEG C of extension 1min40s, instead Answer 40 circulations;Last 72 DEG C of extensions 10min, takes 5 μ lPCR products to carry out 1% agarose gel electrophoresis inspection, -20 DEG C of preservations It is standby.
(Two)DNA reorganizes
The template reorganized using above-mentioned fallibility PCR amplified production as DNA, using pfu as archaeal dna polymerase, by it is following operate into Performing PCR is expanded, and obtained pcr amplification product is the aroG-pheA mutant libraries after DNA reorganization:
Sense primer aroG-f:5’-CGGAATTCATGAATTATCAGAACGACGAT-3’
Anti-sense primer pheA-r:5’-CGGGATCCTCAGGTTGGATCAACAGGCAC-3’;
(Sequence shown in underscore is digestion recognition site)
PCR programs:
(1)94 DEG C, 1min53 DEG C, 1min72 DEG C, 20s, 13 circulations
(2)94 DEG C, 1min55 DEG C, 1min15s72 DEG C, 20s, 25 circulations
(3)94 DEG C, 1min54 DEG C, 1min35s72 DEG C, 20s, 75 circulations
72 DEG C of insulation 10min make extension complete.
PCR system is:
DNTP concentration is 100mM/mL, and upstream and downstream primer concentration is 10 μm of ol/L, fallibility PCR primer concentration 60ng/ μ L。
(Three)The structure of mutant expression library 1
After aroG-pheA mutant library restriction enzymes EcoR I and BamH I after DNA is reorganized are double digested, Be attached with the pBV220 plasmids of identical endonuclease digestion, by connection product Transformed E .coli JM109, carry out screening and Expand culture, obtain the E.coli JM109 bacterium storehouse of the mutant containing pBV220-aroG-pheA.
Plasmid is extracted from E.coli JM109 bacterium storehouse, plasmid is converted into Escherichia coli 10245, obtained containing pBV220- The bacterium storehouse of Escherichia coli 10245 of aroG-pheA mutant, is denoted as mutant expression library 1.
(Four)L-phenylalanine Producing Strain is screened from storehouse 1
The monoclonal of picking mutant expression library 1 to every 150 μ L of hole g/mL concentration of μ containing Amp100 fermentation medium 96 In orifice plate, 37 DEG C, 150rpm culture 48h, 3000rpm centrifugations take supernatant, to be measured.
Three wave bands survey the content of L-phenylalanine in acid system detection fermented supernatant fluid:
1st, the 0.1g/100ml L-phenylalanine aqueous solution is prepared to dilute as standard items, then with 0.1mol/L hydrochloric acid solutions After 1000 times, using 0.1mol/L hydrochloric acid solutions as blank, absorbance A is surveyed206, A208, A222
2nd, fermentation broth sample supernatant is with after n times of distilled water diluting(L-phenylalanine should be in the Sample supernatants finally measured 0.1g/100ml or so, each absorbance is defined between 0.2-0.7), 4000r/min centrifugations 15 minutes.
3rd, take each supernatant to dilute 1000 times with 0.1mol/L hydrochloric acid solutions again, using 0.1mol/L hydrochloric acid as blank, determine Survey absorbance A206, A208, A222
4th, the concentration of phenylalanine in Sample supernatants is calculated according to formula 1(g/100ml).
△ samples=A206 samples+0.2727A208 samples-0.9682A222 samples
△ marks=A206 marks+0.2727A208 marks-0.9682A222 marks
Extension rate:1000
Standard concentration:0.1g/100mL
4 plants of orifice plate L-phenylalanine yield of screening acquisition reach that more than 0.755g/100mL's is excellent from the strain of nearly ten thousand plant mutant Good mutant strain, is denoted as bacterial strain 1- bacterial strains 4.
Same method detection control bacterium Escherichia coli 10245 are only 0.25g/ in the L-phenylalanine yield of orifice plate 100mL。
3rd, recombinant plasmid pBV220-aroG-pheA second of DNA reorganization
(One)Bacterial strain 1- bacterial strains 4 mix the preparation of plasmid
The monoclonal of picking bacterial strain 1- bacterial strains 4 is trained overnight in the LB culture mediums of 3mL μ containing Amp100 g/mL concentration respectively Support, then extract the DNA of bacterial strain 1- bacterial strains 4, the template that 4 kinds of plasmid mixed in equal amounts are reorganized as DNA.
(Two)DNA reorganizes
The template reorganized using the plasmid of above-mentioned mixed in equal amounts as the second round DNA, using pfu as archaeal dna polymerase, by following Operate into performing PCR amplification, obtain pcr amplification product:
Sense primer aroG-f:5’-CGGAATTCATGAATTATCAGAACGACGAT-3’
Anti-sense primer pheA-r:5’-CGGGATCCTCAGGTTGGATCAACAGGCAC-3’;
PCR programs:
(1)94 DEG C, 1min53 DEG C, 1min72 DEG C, 20s, 13 circulations
(2)94 DEG C, 1min55 DEG C, 1min15s72 DEG C, 20s, 25 circulations
(3)94 DEG C, 1min54 DEG C, 1min35s72 DEG C, 20s, 75 circulations
72 DEG C of insulation 10min make extension complete.
PCR system is:
DNTP concentration is 100mM/mL, and upstream and downstream primer concentration is 10 μm of ol/L, mixing plasmid template concentration 75ng/ μL。
(Three)The structure of mutant expression library 2
By pcr amplification product with restriction enzyme EcoR I and BamH I it is double digested after, disappear with identical restriction endonuclease The pBV220 plasmids of change are attached, by connection product Transformed E .coli JM109, are screened and expand culture, are contained The E.coli JM109 bacterium storehouse of pBV220-aroG-pheA mutant.
Plasmid is extracted from E.coli JM109 bacterium storehouse, plasmid is converted to Escherichia coli 10245 respectively, contained The bacterium storehouse of Escherichia coli 10245 of pBV220-aroG-pheA mutant, is denoted as mutant expression library 2.
(Four)L-phenylalanine Producing Strain is screened from storehouse 2
The monoclonal of picking mutant expression library 2 to every 150 μ L of hole g/mL concentration of μ containing Amp100 fermentation medium 96 In orifice plate, 37 DEG C, 150rpm culture 48h, 3000rpm centrifugations take supernatant, to be measured.
Three wave bands survey the content of L-phenylalanine in acid system detection fermented supernatant fluid, and method is with step 2(Four).
Screening obtains the bacterial strain that one plant of orifice plate L-phenylalanine yield reaches 0.985g/100mL from nearly ten thousand mutant strains, will It is named as Escherichia coli MD1078.The yield of the orifice plate L-phenylalanine of remaining bacterial strain is typically arrived in 0.38g/100mL Between 0.85g/100mL.
Escherichia coli MD1078(Escherichia coli MD1078)Chinese allusion quotation is preserved on October 25th, 2013 Type culture collection(Abbreviation CCTCC;Address:Chinese Wuhan Wuhan Universitys;Postcode:430072), deposit number is CCTCC NO:M 2013509。
Sour (L-phenylalanine) ability of the production of embodiment 2, bacterial strain MD1078 and Escherichia coli 10245
Escherichia coli MD1078 and the 50L fermentation tank acid producing abilities of Escherichia coli 10245
First, seed culture(Using 30L automatic fermenters, seed culture medium liquid amount is 20L):By Escherichia coli MD1078 and Escherichia coli 10245 are inoculated in seed culture medium respectively, and 30L seed fermentation tanks control parameter is 36 DEG C, dissolved oxygen (DO)For 40%-60%, concentration of glucose is 30g/L in seed culture medium, and incubation time is 12 hours, obtains seed liquor(Seed Liquid OD610=30).
2nd, fermented and cultured(Using 100L automatic fermenters, fermentation liquid culture medium liquid amount is 50L):Sent out using 100L Fermentation tank is fermented.Seed liquor is inoculated in fermentation medium by 25% volume, fermentation tank control parameter is 36 DEG C, dissolved oxygen (DO)When glucose content in 35%-50%, fermentation system is less than 15g/L, 700g/L glucose is added automatically by fermentation tank The aqueous solution so that the glucose content of fermentation system is maintained between 10g/L-15g/L, fermentation time is 48 hours.
After Escherichia coli MD1078 and 48 hours zymotic fluid 15mL4500rpm of Escherichia coli 10245 centrifugations, it is taken to send out Ferment supernatant is diluted with water to progress liquid phase detection after 200 times of volumes.
3rd, liquid phase detects the content of L-phenylalanine in fermented liquid supernatant
L-phenylalanine(Phe is denoted as below)The assay method of concentration often uses assay method, i.e., efficient liquid using amino acid Phase chromatogram(HPLC)Derivatization Method(Rapid,accurate,senstitive,and reprodicobLe HPLC anaLysis of amino acida.Henderson,J.W,Ricker,R.D.,BidLingmeyer,B.A.,Woodward, C.,AgiLent TechnoLogier,ΜSA,2000).
L-phenylalanine concentration in sample solution(μg/mL)=f1/f2×C;
The peak area of L-phenylalanine/interior target peak area in f1=sample solution;
The peak area of L-phenylalanine/interior target peak area in f2=amino acid standard liquid;
L-phenylalanine in C=amino acid standard liquid(μg/mL).
Chromatographic column:AgeLa VenusiL AA posts, (4.6*250mm, 5 μm);
Column temperature:40℃;
Detection wavelength:254nm;
Mobile phase A:15.2g anhydrous sodium acetates are taken, add water 1850mL, pH to 6.5, Ran Houjia is adjusted with glacial acetic acid after dissolving 140mL acetonitriles, are mixed, with 0.45 μm of membrane filtration;
Mobile phase B:Acetonitrile and water are according to volume ratio 4:1 prepares;
Flow velocity:1mL/min;
Nor-leucine inner mark solution:Take nor-leucine(Nle)10mg, plus 10mL0.1moL/L aqueous hydrochloric acid solutions, dissolving;
Concentration of phenylalanine is 2.5 μm of oL/mL in amino acid standard liquid;
The derivative of amino acid standard liquid and sample solution, is carried out as follows:
(1)Amino acid standard liquid and analyte sample fluid are measured respectively(The Escherichia coli MD1078 and large intestine bar of step 2 The dilution of the fermented supernatant fluid of bacterium 10245)Each 200 μ L, are respectively placed in 1.5mL centrifuge tubes;
(2)The μ L of nor-leucine inner mark solution 20 are added in each centrifuge tube;
(3)100 μ L triethylamine acetonitrile solutions are added in each centrifuge tube(8.6mL acetonitriles are added in 1.4mL triethylamines, are mixed It is even)With 100 μ L phenyl isothiocyanate acetonitrile solutions(25 μ L phenyl isothiocyanates add 2mL acetonitriles, mix), mix, room temperature is put Put 1 hour;
(4)400 μ L n-hexanes are added in each centrifuge tube, 10min is placed after shaking;
(5)Remove a layer solution, the phenylalanine after as deriving, referred to as PTC- phenylalanines, with 0.45 μm of pin type filter Filtering;
(6)The μ L of filtrate 200, plus the dilution of 800 μ L water are taken, is shaken up, the μ L of sample introduction 10.
Gradient elution process:0-2min eluent is mobile phase A;2-14min eluent is by mobile phase A and stream Dynamic phase B compositions, volumn concentration of the mobile phase A in eluent is by 100% linear decline to 93%;14-29min elution Liquid is made up of mobile phase A and Mobile phase B, and volumn concentration of the mobile phase A in eluent is by 93% linear decline to 70%;The 29-32min eluent is made up of mobile phase A and Mobile phase B, and volumn concentration of the mobile phase A in eluent is by 70% line Property drops to 50%;32-33min eluent is made up of mobile phase A and Mobile phase B, volume of the mobile phase A in eluent Percentage composition is by 50% linear rise to 100%;33-39min eluent is mobile phase A;39-45min eluent by Mobile phase A and Mobile phase B composition, volumn concentration of the mobile phase A in eluent is by 100% linear decline to 0%;The 45min eluent is Mobile phase B.
The HPLC spectrograms of amino acid standard liquid are as shown in Figure 2.In Fig. 2, Nle peak area is 1301274, Phe peak Area is 3700021, and retention time is 33.65min.
The HPLC spectrograms of the dilution of Escherichia coli MD1078 fermented liquid supernatants are as shown in Figure 3.In Fig. 3, Nle peak area It is 7746327 for 1301520, Phe peak area, retention time is 33.6min.
The HPLC spectrograms of the dilution of the fermented liquid supernatant of Escherichia coli 10245 are as shown in Figure 4.In Fig. 4, Nle peak area It is 1873312 for 1302058, Phe peak area, retention time is 33.6min.
It is 86.5g/L, Escherichia coli to calculate the L-phenylalanine concentration obtained in Escherichia coli MD1078 fermented liquid supernatants L-phenylalanine concentration in 10245 fermented liquid supernatants is 20.8g/L, and Escherichia coli MD1078 produces L- than Escherichia coli 10245 Phenylalanine improves about 315%.
The average production acid of the bacterial strain of current domestic production L-phenylalanine(L-phenylalanine)Typically in 62g/L, large intestine bar Bacterium MD1078 has significant production L-phenylalanine ability, there is very high production application value.

Claims (10)

1. one plant of recombination bacillus coli MD1078 (Escherichia coli MD1078), its deposit number is CCTCC NO:M 2013509。
2. deposit number is CCTCC NO:Application of M 2013509 Escherichia coli in production L-phenylalanine.
3. a kind of method for producing L-phenylalanine, comprises the following steps:It is CCTCC NO by deposit number:M's 2013509 Escherichia coli fermentation culture, obtains L-phenylalanine.
4. method according to claim 3, it is characterised in that:The fermentation medium used in the fermented and cultured is every 100ml composition is as follows:
Glucose 2g, ammonium sulfate 2g, sodium citrate 0.05g, magnesium sulfate 0.08g, potassium dihydrogen phosphate 0.1g, dipotassium hydrogen phosphate 0.1g, dusty yeast 0.1g, sodium glutamate 0.05g, MnCl20.2mg, niacin 1mg, CoCl20.01mg, ZnSO40.1mg, CaCl20.5mg, VB11mg, MnCl20.2mg, tyrosine 3mg, surplus is water.
5. the method according to claim 3 or 4, it is characterised in that:The condition of the fermentation is 36 DEG C, dissolved oxygen 35%- 50%, start to add glucose when the glucose content in fermentation system is less than 15g/L, be maintained at the content of glucose Between 10g/L-15g/L.
6. method according to claim 5, it is characterised in that:The time of the fermentation is 48 hours.
7. the method according to claim 3 or 4, it is characterised in that:The deposit number is CCTCC NO:M 2013509 Escherichia coli be by seed liquor access fermentation medium.
8. method according to claim 7, it is characterised in that:The composition for preparing the every 100ml of culture medium of the seed liquor It is as follows:Glucose 3g, ammonium sulfate 1g, magnesium sulfate 0.08g, potassium dihydrogen phosphate 0.1g, dipotassium hydrogen phosphate 0.1g, dusty yeast 0.2g, Sodium glutamate 0.08g, MnCl20.25mg, CoCl20.005mg, ZnSO40.15mg, CaCl20.5mg, VB11mg, MnCl2 0.2mg, tyrosine 3mg, surplus is water.
9. method according to claim 7, it is characterised in that:Condition of culture when prepared by the seed liquor is 36 DEG C, molten Oxygen is 40%-60%, and the content of glucose is 30g/L.
10. method according to claim 9, it is characterised in that:The incubation time of the seed liquor is 12 hours.
CN201310752842.8A 2013-12-31 2013-12-31 One plant production L phenylalanines bacterial strain and its application Expired - Fee Related CN104745500B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310752842.8A CN104745500B (en) 2013-12-31 2013-12-31 One plant production L phenylalanines bacterial strain and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310752842.8A CN104745500B (en) 2013-12-31 2013-12-31 One plant production L phenylalanines bacterial strain and its application

Publications (2)

Publication Number Publication Date
CN104745500A CN104745500A (en) 2015-07-01
CN104745500B true CN104745500B (en) 2017-10-20

Family

ID=53585761

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310752842.8A Expired - Fee Related CN104745500B (en) 2013-12-31 2013-12-31 One plant production L phenylalanines bacterial strain and its application

Country Status (1)

Country Link
CN (1) CN104745500B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111187794B (en) * 2020-04-03 2023-06-16 杭州巴洛特生物科技有限公司 Method for preparing L-phenylalanine by using escherichia coli fermentation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101717769A (en) * 2009-12-08 2010-06-02 福建省麦丹生物集团有限公司 Method for improving acid production rate of L-phenylalanine gene engineering bacteria
CN102604882A (en) * 2012-03-31 2012-07-25 福建省麦丹生物集团有限公司 Engineering bacterium for producing L-phenylalanine and application thereof
CN103146773A (en) * 2013-03-08 2013-06-12 江南大学 Method for enhancing L-phenylalanine exocytosis of escherichia coli

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101717769A (en) * 2009-12-08 2010-06-02 福建省麦丹生物集团有限公司 Method for improving acid production rate of L-phenylalanine gene engineering bacteria
CN102604882A (en) * 2012-03-31 2012-07-25 福建省麦丹生物集团有限公司 Engineering bacterium for producing L-phenylalanine and application thereof
CN103146773A (en) * 2013-03-08 2013-06-12 江南大学 Method for enhancing L-phenylalanine exocytosis of escherichia coli

Also Published As

Publication number Publication date
CN104745500A (en) 2015-07-01

Similar Documents

Publication Publication Date Title
CN107267578A (en) The method that microbial fermentation produces N acetyl D Glucosamines and/or D glucosamine salts
WO2014121724A1 (en) 5-aminolevulinic acid high-yield bacterial strain, preparation method and use thereof
CN109402158A (en) A kind of recombinant expression plasmid carrier, metabolic engineering bacteria and production method producing fucosyllactose
CN104560844A (en) Escherichia coli engineering bacterium for high-yield tetrahydropyrimidine and applications of escherichia coli engineering bacterium
CN107502585A (en) One plant of bacillus licheniformis engineering bacteria for efficiently synthesizing poly- γ glutamic acid
CN105420154B (en) Double-gene knockout recombinant rhodococcus, construction method and application thereof
CN103409485A (en) Method for improving adenosine fermentation output through feeding organic nitrogen source
CN102604882B (en) Engineering bacterium for producing L-phenylalanine and application thereof
CN104593442A (en) A method of producing ectoine by high-density culture of recombinant escherichia coli
CN102994439A (en) Escherichia coli recombinant strain producing shikimic acid, and construction method and application thereof
KR20160107202A (en) Carbohydrate-enriched recombinant microorganisms
CN104745520B (en) A kind of strain excellent of high yield L phenylalanines and its application
CN112725319B (en) Alginate lyase FaAly7 with polyG substrate specificity and application thereof
CN110591989A (en) High-yield L-tryptophan engineering strain and application thereof
CN104480058A (en) High yield L-leucine engineering bacterium and application thereof
CN111394288B (en) Recombinant corynebacterium glutamicum, construction method thereof and method for producing tetrahydropyrimidine by using recombinant corynebacterium glutamicum
CN111690690A (en) Saccharomyces cerevisiae for producing farnesene
CN105368767A (en) Recombinant bacillus subtilis for expressing cellobiose-2-epimerase based on D-alanine defective screening, and construction method of recombinant bacillus subtilis
CN104046586B (en) One strain gene engineering bacterium and the application in producing (2R, 3R)-2,3-butanediol thereof
CN111019960B (en) Method for preparing spermidine by enzyme method
CN101220338A (en) Glutathione produced bacterial strain and construction method thereof
CN104946552A (en) Gene engineering strain capable of safely and efficiently producing Phenazino-1-carboxylic acid and application thereof
Liu et al. Site-specific integration and constitutive expression of key genes into Escherichia coli chromosome increases shikimic acid yields
CN104745500B (en) One plant production L phenylalanines bacterial strain and its application
CN108531518A (en) A method of it improving Escherichia coli and accumulates pyruvic acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Wu Weibin

Inventor after: Shi Qiaoqin

Inventor after: Weng Xueqing

Inventor after: Huang Qingeng

Inventor after: Zhao Yanyu

Inventor after: Chen Bingsheng

Inventor after: Wu Songgang

Inventor before: Shi Qiaoqin

Inventor before: Wu Weibin

Inventor before: Weng Xueqing

Inventor before: Huang Qingeng

Inventor before: Zhao Yanyu

Inventor before: Chen Bingsheng

Inventor before: Wu Songgang

CB03 Change of inventor or designer information
TA01 Transfer of patent application right

Effective date of registration: 20170908

Address after: 365599 Fujian province Shaxian County Qiujiang Street Yang Fang Cun Qiao Dan in Industrial Co. Ltd.

Applicant after: Shaxian County new creation Biological Technology Co.,Ltd.

Address before: 365500 Jinsha hi tech park, Fujian, Sanming City Province

Applicant before: FUJIAN MAIDAN BIOLOGY GROUP Co.,Ltd.

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171020

Termination date: 20211231

CF01 Termination of patent right due to non-payment of annual fee